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Abstract –The role of oxidative stress in cisplatin (CP) toxicity and its prevention by pretreatment with selenium (Se) 
was investigated. Male Wistar albino rats were injected with a single dose of cisplatin (7.5 mg CP/kg b.m., i.p.) and 
selenium (6 mg Se/kg b.m, as Na2SeO3, i.p.) alone or in combination. The results suggest that CP intoxication induces 
oxidative stress and alters the glutathione redox status: reduced glutathione (GSH), oxidized glutathione (GSSG) and 
the GSH/GSSG ratio (GSH RI), resulting in increased lipid peroxidation (LPO) in rat liver. The pretreatment with 
selenium prior to CP treatment showed a protective effect against the toxic influence of CP on peroxidation of the 
membrane lipids and an altering of the glutathione redox status in the liver of rats. From our results we conclude that 
selenium functions as a potent antioxidant and suggest that it can control CP-induced hepatotoxicity in rats. 
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INTRODUCTION 
Oxidative stress is caused by an imbalance between 
the production of reactive oxygen species (ROS) 
and a biological system’s ability to readily detoxify 
the reactive intermediates or easily repair the 
resulting damage. Disturbances in this normal 
redox state can cause toxic effects through the 
production of peroxides and free radicals that 
damage all components of the cell, including 
proteins, lipids and DNA (Halliwell and Gutteridge, 
2007). Oxidative stress (a deleterious imbalance 
between the production and removal of reactive 
oxygen/nitrogen species) plays a key role in the 
pathogenesis of many diseases, including cancer, 
inflammation, kwashiorkor (predominantly a 
protein deficiency), seizure, Alzheimer’s disease, 
Parkinson’s disease, sickle-cell anemia, liver disease, 
cystic fibrosis, HIV, AIDS, infection, heart attack, 
stroke, and diabetes (Matés, 2000).  
Cisplatin (cis-diamminedichloroplatinum II, CP) is 
one of the most effective chemotherapeutic agents and 
plays a major role in the treatment of a variety of 
human solid tumors including those of the head, neck, 
testis, ovary, and breast. However, high-doses 
administered to patients produce nephrotoxic side 
effects and the dose of CP must often be limited 
(Jordan and Carmo-Fonseca, 2000; Yoshida et al., 
2000). Hepatotoxicity is not considered as a dose 
limiting toxicity for CP, but liver toxicity can occur 
when the aneoplastic drug is administrated at high 
doses (Zicca et al., 2004; Pratibha et al., 2006). The 
treatment of tumor cells with CP provokes several 
responses including membrane peroxidation, 
dysfunction of mitochondria, inhibition of protein 
synthesis and DNA damage (Cohen and Lippard, 2001; 
Sadowitz et al., 2002). Formation of free radicals, 
leading to oxidative stress, has been shown to be one of 
the pathogenic mechanisms of these side effects (Jordan 
and Carmo-Fonseca, 2000). 
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Recent studies have focused on the role of 
antoxidants in CP toxicity. Administration of 
antioxidants such as NAC and GSH (Rybak et al., 
1999), vitamin C (Antunes et al., 2000), vitamin E 
and selenium (Caffrey and Frenkel, 2000; Antunes 
et al., 2001; Naziroğlu et al., 2004) before treatment 
with CP has been used to protect against toxicity in 
human and experimental animals. 
Among antioxidant micronutrients, selenium 
(Se) is an essential dietary trace element which plays 
an important role in a number of biological 
processes in humans and many other forms of life. 
Deficiency of this element induces some 
pathological conditions such as cancer, coronary 
heart disease, and liver necrosis (Saito et al., 2003; 
Agay et al., 2005). Se is an essential component of 
several enzymes such as glutathione peroxidase 
(GSH-Px), thioredoxin reductase (TR) and 
selenoprotein P (SeP), which contains Se as a 
selenocysteine. It is also well known that Se is 
essential for cell culture when a serum-free medium 
is used (Kim and Combs, 1993; Saito et al., 2003). 
Many experimental studies in animals have 
demonstrated the ability of Se to prevent 
carcinogenesis. A recent widely publicized chemo-
prevention study has shown that selenium 
supplements can decrease the incidence of certain 
types of cancer (Spallhoz, 1994; Conklin, 2000). 
The aim of the present study was to investigate 
a protective effect of Se pretreatment on LPO 
concentration and the glutathione redox status 
(GSH, GSSG and GSH RI) in the liver of rats 
acutely treated with CP. 
MATERIAL AND METHODS 
Male Wistar albino rats (about 3 months old, 
weighing 250 ± 20 g) were used. The animals were 
kept at 21±2oC, fed with pellet rat diet and exposed 
to a 12 h light/12 h dark cycle. The animals were 
randomly divided into four groups. The first group 
was used as a control (C). The rats of the 
experimental groups (2) were injected i.p. with a 
single dose of 7.5 mg CP/kg body mass in 0.1 ml 
saline, (3) i.p. with a single dose of 6 mg Se/kg body 
mass as Na2SeO3 in 0.1 ml saline and (4) Se + CP (in 
the above-mentioned amounts). The animals were 
treated with Se 1 h prior to treatment with CP. Each 
group consisted of 6 animals. All chemicals were 
from Sigma (St. Louis, Mo. U.S.A.).  
After the treatment (48 h after injection), all 
animals were killed by decapitation. Before 
extraction of the liver, perfusion through the portal 
vein with ice-cold saline was done in order to 
remove the remaining blood. Tissues were stored at 
-80 °C until further analysis.  
The tissues were dissected, thoroughly washed 
with ice-cold saline, weighed, minced and 
homogenized with a Thomas Sci Co. glass-type 
homogenizer (Teflon pestle) at 4°C (10% w/v) using 
1.15% KCl for lipid peroxide (LPO) determination. 
The concentration of LPO measured as thio-
barbituric acid reactive substances (TBARS) in the 
tissues of liver was assayed by the method of 
Ohkawa et al. (1979) using thiobarbituric acid 
(TBA. In this reaction, a colored complex was 
formed and absorbance was determined spectro-
photometrically (UV/VIS Spectrophotometer, Jan-
way, GBR) at 530 nm. The results were expressed in 
nmol MDA/g tissue using a molar extinction 
coefficient for MDA of 1.56 x 105 M-1 cm-1. 
Tissue samples for glutathione (reduced 
glutathione-GSH and oxidized glutathione-GSSG) 
assays were homogenized on ice with 20 volumes of 
precipitating solution (1.5 mL 100 mmol/L Na-
phosphate/5 mmol/L EDTA buffer, pH 8.0 and 0.4 
mL 25% metaphosphoric acid). The total 
homogenate was centrifuged at 4°C at 10,000 g for 
30 minutes to obtain clear supernatants for the 
GSH and GSSG assay.  
The concentrations of GSH were determined 
based on GSH oxidation with DTNB (5, 5′-dithio-
bis-2-nitrobenzoic acid), (Beutler, 1975) and the 
concentration of GSSG was determined enzy-
matically by glutathione reductase after the 
inhibition of GSH oxidation by NEM (N-
ethylmaleimide) (Beutler, 1975). The optical density  
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 of the reaction product was read immediately at 
412 nm on a spectrophotometer (UV/VIS Spectro-
photometer, Janway, GBR). The concentrations of 
GSH and GSSG were expressed as nmol/g protein.  
Since it is a usable marker of the reciprocal 
relationship between GSH and GSSG, the 
glutathione redox index (GSH RI) was also 
estimated. GSH RI was calculated and expressed in 
arbitrary units. 
Protein contents in various samples were 
determined by the method of Lowry et al. (1951) 
using Folin’s reagent and bovine serum albumin 
(BSA) as standard.  
The data were expressed as the mean ± S.E.M. 
and were analyzed by means of one-way analysis of 
variance (ANOVA). Statistical evaluation of the 
data was done following Student’s t-test. A 
difference was considered significant at p < 0.05. 
RESULTS 
The concentration of LPO in the liver of rat is 
shown in Fig. 1. The LPO concentration 
significantly increased in the liver of rats after 
acute administration of CP (p < 0.05), while Se  
 pretreatment reversed this change to control 
values.  
The data presented in Figures 2-4 show significant 
changes in the glutathione redox status   (GSH, 
GSSG and GSH RI) during the treatment of rats 
with CP and Se. The results of the experiments 
show that the concentrations GSH in the liver 
significantly decreased (p < 0.05) in the CP-treated 
rats with respect to the control animals (Fig. 2). 
Pretreatment with Se reversed the concentrations of 
GSH to the control levels. 
In the animals exposed to CP, the concentration 
of GSSG (Fig. 3), as well as GSH RI (Fig. 4) 
significantly increased in respect to the controls (p 
< 0.05). The pretreatment with Se prior to CP 
intoxication reversed these changes. The 
concentration of GSSG and GSH RI significantly 
decreased in comparison to the animals given CP 
alone (p < 0.05).  
DISCUSSION 
Cisplatin is a potent antitumor drug. It is a widely 
used chemotherapeutic agent against various types 
of malignant tumors (Jordan and Carmo-Fonseca, 
2000; Mansour et al., 2006). High doses of CP have 
also been known to produce hepatotoxicity and  
 
Figure 1. Concentration of lipid peroxides (LPO) in the rat 
livers of control and experimental groups. Results are expressed
as means ± S.E.M. n = 6 for each treatment group. *Statistically
different from the control group, p < 0.05 and #statistically 
different from the CP - treated group, p  < 0.05. 
 
Figure 2. Concentration of reduced glutathione (GSH) in the 
rat livers of control and experimental groups. Results are 
expressed as means ± S.E.M. n = 6 for each treatment group. 
*Statistically different from the control group, p < 0.05 and 
#statistically different from the CP - treated group, p  < 0.05. 
78 I. TRBOJEVIĆ ET.AL. 
 several studies suggest that supplemental anti-
oxidants can reduce cisplatin-induced hepatoto-
xicity (Zicca et al., 2004; Koc et al., 2005; Mansour 
et al., 2006; Pratibha et al., 2006).  
There are many studies which have demonstrated 
the involvement of oxidative stress, lipid peroxidation 
and mitochondria dysfunction in CP-induced liver and 
kidney toxicity (Antunes et al., 2000; Jordan and 
Carmo-Fonseca, 2000; Mansour et al., 2006; Atasayar et 
al., 2009). A mechanism by which CP exerts its 
cytotoxicity is through the generation of ROS (Antunes 
et al., 2001; Atasayar et al., 2009). The administration of 
CP causes an increase in lipid peroxide levels and a 
decrease in the activity of antioxidant defense enzymes, 
as well as in the concentrations of non-enzymatic 
components of AOS that prevent, or protect against, 
lipid peroxidation in the tissues (Naziroğlu et al., 2004). 
It is accepted that both correlate to oxidative stress and 
cause an imbalance between the generation of oxygen 
derived radicals and the organism's antioxidant 
potential (Halliwell and Gutteridge, 2007). 
Lipid peroxidation is one of the main 
manifestations of oxidative damage and has been 
found to play an important role in the toxicity of 
many xenobiotics (Matés, 2000). Several patho 
physiological mechanisms have been proposed to 
explain the increased LPO and decreased 
  
antioxidant levels in the CP toxicity. Moreover, it 
has been shown that various antioxidants and 
antioxidant defense systems protect cells from the 
CP induced toxicity.  
The prevention of lipid peroxidation is essential for 
all aerobic organisms; therefore the organism is well 
equipped with antioxidants that directly or indirectly 
protect cells against the adverse effects of xenobiotics, 
carcinogens and toxic radicals (Halliwell and 
Gutteridge, 2007). The role of antioxidants in reversing 
this oxidative stress has been of long-standing interest 
to basic scientists and clinicians (Matés, 2000). 
The data obtained in our study (Fig. 1) confirm 
that acute intoxication with CP causes a significant 
increase of LPO concentration in the liver of rats. 
Pretreatment with Se was very effective in the 
prevention of the oxidative damage induced by CP, 
which resulted in a significantly lower LPO 
concentration in liver. These results can be 
explained by the important role of Se in preventing 
lipid peroxidation and in protecting the integrity 
and functioning of tissues and cells. 
Many experimental studies in animals have 
demonstrated the ability of Se to prevent carcino-
genesis, and epidemiological studies have suggested 
 
Fig. 4. Glutathione redox index (GSH RI) in the rat livers of
control and experimental groups. Results are expressed as 
means ± S.E.M. n = 6 for each treatment group. *Statistically 
different from the control group, p < 0.05 and #statistically 
different from the CP - treated group, p < 0.05. 
 
Figure 3. Concentration of oxidized glutathione (GSSG) in the
rat livers of control and experimental groups. Results are 
expressed as means ± S.E.M. n = 6 for each treatment group.
*Statistically different from the control group, p < 0.05 and
#statistically different from the CP - treated group, p < 0.05. 
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that a decreased Se status in humans is associated 
with an increased risk of cancer (Agay et al., 2005). 
Supplementation of the antioxidant vitamin E and 
Se has been reported to inhibit lipid peroxide in 
various conditions such as CP-induced nephro-
toxicity and hepatotoxicity (Naziroğlu et al., 2004). 
Recent studies have focused on the role of 
antioxidants in CP toxicity. Administration of 
antioxidants such as vitamin E and vitamin C, 
curcumin or Se before and during treatment with 
CP has been used to protect against toxicity in 
humans and experimental animals (Spallhoz, 1994; 
Rybak et al., 1999; Antunes et al., 2000 and 2001; 
Caffrey and Frenkel, 2000; Naziroğlu et al., 2004; 
Atasayar et al., 2009). 
The reduction-oxidation (redox) state of a cell 
is largely determined by the balance between 
generated ROS and endogenous expression of thiol 
buffers such as glutathione (Shelly, 2009). GSH is a 
ubiquitous intracellular peptide with diverse 
functions that include detoxification, antioxidant 
defense, maintenance of thiol status, and 
modulation of cell proliferation. GSH is synthesized 
in the cytosol of all mammalian cells in a tightly 
regulated manner (Sies, 1999; Shelly, 2009). The 
measurement of GSH and GSSG in biological 
samples is essential for the evaluation of the redox 
and detoxification status of cells and tissues in 
relation to the protective role of GSH against 
oxidative and free-radical-mediated cell injury 
(Richie et al., 1996). In healthy cells and tissue, 
more than 90% of the total GSH pool is in the 
reduced form (GSH) and less than 10% exists in the 
disulfide form (GSSG). An increased GSSG-to-GSH 
ratio is considered indicative of oxidative stress 
(Griffith, 1999; Shelly, 2009). 
The results suggest that CP intoxication induces 
oxidative stress and alters the glutathione redox 
status (GSH, GSSG and GSH RI), (Figs. 2 - 4) in the 
rat liver. The CP-induced oxidative damage has 
been demonstrated by the increased lipid 
peroxidation and inhibition of enzymes required to 
prevent such oxidative damage (Antunes et al., 
2000; Naziroğlu et al., 2004). In addition, GSH, the 
most abundant intracellular thiol and a critical 
cellular antioxidant, executes the intracellular 
inactivation of CP and detoxification of ROS as a 
mechanism for CP resistance (Atasayar et al., 2009). 
Accordingly, the depletion of GSH, an increase in 
GSSG and the lowering of GSH RI in the blood, 
liver and kidney were consistent with the 
accumulation of CP in these tissues. These changes 
seem to be due to the generation of ROS (Atasayar 
et al., 2009). GSH is known to protect the cellular 
system against the toxic effects of lipid peroxidation 
(Griffith, 1999). GSH functions as a direct free 
radical scavenger, a co-substrate for GSH-Px 
activity and a co-factor for many enzymes and 
forms conjugated in endogenous and xenobiotic 
reactions (Griffith, 1999; Sies, 1999; Shelly, 2009).  
GSH is necessary for resistance to oxidative 
stress through detoxification of ROS. It can also 
detoxify many endogenous toxins, including CP, 
through the formation of GSH adducts (Hrubisko 
et al., 1993; Chen et al., 1995). Also, the GSH redox 
cycle, which includes GSH, GSH-Px and GR, plays 
an important role in the detoxification of ROS that 
are generated by CP, so as to protect cells from 
potential toxicity and carcinogenesis (Hrubisko et 
al., 1993; Griffith, 1999; Atasayar et al., 2009). GSTs 
are a family of enzymes that catalyze the 
conjugation of GSH to a variety of substrates. 
Several isoforms of GST have been shown to bind 
CP in vivo (Hrubisko et al., 1993; Sadzuka et al., 
1994). Of the studies in which increased resistance 
to CP was observed, none determined whether the 
inactivation of CP was due to GST binding to the 
CP or catalyzing its conjugation to GSH. 
Increased intracellular GSH concentrations 
correlate with decreased platinum-DNA binding in 
freshly isolated peripheral blood mononuclear cells 
(Sadowitz et al., 2002). Studies of tumor cell lines 
have shown a correlation between increased levels 
of intracellular GSH and resistance to CP 
(Hrubisko et al., 1993; Chen et al., 1995).  
In the present study, Se also reduced the cellular 
toxicity caused by CP, induced ROS and protected 
the liver antioxidant system. The treatment with Se 
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reversed the CP induced alterations in liver GSH, 
GSSG or GSH RI (Figs. 2 - 4). Se can reduce the 
nephrotoxicity and hepatotoxicity of CP without 
reducing the antitumor activity of the drug. The 
protection correlates with higher levels of Se in the 
kidney and with higher levels of GSH in the kidney, 
both compared to tumors. Selenite is metabolized 
into selenols, specifically into methylselenol and 
glutathionylselenol. This bioactivation of selenite 
into selenols is a GSH-dependent process. HPLC 
with on-line radioactivity detection of 195mPt 
showed that methylselenol was capable of forming a 
complex with CP in vitro. 1H-NMR gave evidence 
that the complex contained one or more Pt—Se—
CH3 bond. Attempts to obtain further structural 
information by Desorption Chemical Ionization 
and Fast Atom Bombardment mass-spectrometry 
failed. It is proposed that the formation of a CP-
selenol complex also takes place in vivo, especially 
in the kidney, thereby preventing CP to exert its 
nephrotoxic activity (Caffrey and Frenkel, 2000; 
Antunes et al., 2001; Naziroğlu et al., 2004; Agay et 
al., 2005). 
In conclusion, the obtained data in our study 
suggest that CP intoxication induces oxidative 
stress and alters the glutathione redox status (GSH, 
GSSG and GSH RI), resulting in increased lipid 
peroxidation in the rat liver. Se inhibits LPO, thus 
preventing free-radical mediated oxidant injuries. 
Treatment with Se significantly prevents CP-
induced liver damage. Our results show that Se may 
ameliorate CP-induced oxidative stress by 
decreasing LPO and altering the glutathione redox 
status in the liver of rats, thus demonstrating 
protection from CP-induced oxidative damage. 
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У нашој студији испитивана је улога 
оксидационог стреса у токсичности цисплатина 
(СР) и његова превенција претретманом 
селеном (Se). Мужјаци Wistar albino пацова су 
иницирани једном дозом цисплатина (7.5 mg 
CP/kg т.м., и.п.) и селена (6 mg Se/kg т.м, као 
Na2SeO3, и.п.) појединачно или у комбинацији. 
Резултати показују да интоксикација СР узро-
кује оксидациони стрес и промену глутатион 
редокс статуса: редукованог (GSH), оксидованог 
(GSSG) и GSH/GSSG индекса (GSH RI), као и  
повећање липидне пероксидације (LPO) у јетри 
пацова. Третман Se који је претходио третману 
СР показао је заштитне ефекте против ток-
сичног деловања СР на пероксидацију липида 
мемебране и промену глутатион редокс статуса у 
јетри пацова. На основу наших резултата 
закључујемо да Se, делује као снажан анти-
оксиданс и да може имати улогу у контроли СР 
индуковане хепатотоксичности код пацова.  
 
